Please use this identifier to cite or link to this item: https://ptsldigital.ukm.my/jspui/handle/123456789/456152
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorNg Shiow Fern, Assoc. Prof. Dr.
dc.contributor.authorChua Siaw Kim (P89753)
dc.date.accessioned2023-09-11T08:03:08Z-
dc.date.available2023-09-11T08:03:08Z-
dc.date.issued2022-03-30
dc.identifier.otherukmvital:128315
dc.identifier.urihttps://ptsldigital.ukm.my/jspui/handle/123456789/456152-
dc.descriptionPalm glyceryl monocaprylate (GMCY), a medium chain monoglycerides derived from palm kernel oil, has been reported to have antibacterial properties. However, there is a lack of study on the development of functional formulation using palm GMCY for wound application. In this study, the potential application GMCY as antibacterial nanoformulation for the treatment of infected wounds was explored. First, the antibacterial activity of GMCY was tested against three common wound bacteria, namely Escherichia coli, Staphylococcus aureus dan Pseudomonas aeruginosa using the broth dilution method. It was found that GMCY exhibited bactericidal activities against S. aureus and E. coli with the minimum bactericidal concentration of GMCY at 1% (w/w). Electron microscopy observation on the bacteria morphology demonstrated that increment in GMCY concentration caused more severe damaged to the cell membrane. Based on the results of nanoemulsion optimization study using response surface methodology (RSM), it was found that there was a direct correlation between GMCY concentration with the particle size and polydispersity index of the nanoemulsion. Through the RSM models developed, an optimized nanoemulsion containing 1% (w/w) GMCY (GMCY-NE) that has the characteristics of 120 nm in particle size, -16.67 mV in zeta potential value and 0.1 polydispersity index was obtained. The performance of GMCY-NE was evaluated through in vivo infected wound healing study using Sprague-Dawley rats. The healing rate was compared with nanoemulsion without GMCY (Blank-NE). Additionally, two nanoemulsions containing 0.05% (w/w) gentamicin sulfate, with (GMCY-GE-NE) and without (GENE) 1% (w/w) GMCY, were also prepared as comparison. The positive control of the study was a commercial cream containing 1% (w/w) gentamicin sulfate. Based on the results obtained, it was found that the wounds treated with GMCY-GE-NE and GMCY-NE healed fastest among all the treatment groups. Histological analysis of the recovered wounds also showed that GMCY-NE demonstrated better wound healing in terms of skin thickness where the recovered skin layers were found to be most similar to normal healthy skin. Formation of hair follicles was also more apparent in the GMCY-NE treated group. The findings of this study suggest that GMCY could be further explore for use in the treatment of infected wounds,Ijazah Sarjana Sains
dc.language.isoeng
dc.publisherUKM, Kuala Lumpur
dc.relationFaculty of Pharmacy / Fakulti Farmasi
dc.rightsUKM
dc.subjectAnti-Bacterial Agents
dc.subjectWounds
dc.subjectUniversiti Kebangsaan Malaysia -- Dissertations
dc.subjectDissertations, Academic -- Malaysia
dc.titleDevelopment of palm glyceryl monocaprylate nanoemulsion with antibacterial properties for wound healing application
dc.typetheses
dc.format.pages125
Appears in Collections:Faculty of Pharmacy / Fakulti Farmasi

Files in This Item:
File Description SizeFormat 
ukmvital_128315+Source01+Source010.PDF
  Restricted Access
4.64 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.